M2Bio Sciences Inc (WUHN)
0.00
USD |
OTCM |
Apr 22, 16:00
Price Chart
Key Stats
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 100.00% |
Profile
M2Bio Sciences Inc is a United States-based nutraceutical biotechnology company. It focuses on alternative plant-based cannabinoids and psilocybin medical research that is into the development and commercialization of CBD and mushrooms-based products. The company's brands include Dr. AnnaRx, Medspresso, and Handcrafted Delight. It is also into research with psilocybin that aims to develop new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. |
URL | https://www.m2bio.co |
Investor Relations URL | N/A |
HQ State/Province | Nevada |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Small Cap/Value |
Next Earnings Release | N/A |
Last Earnings Release | Apr. 01, 2010 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
M2Bio Sciences Inc is a United States-based nutraceutical biotechnology company. It focuses on alternative plant-based cannabinoids and psilocybin medical research that is into the development and commercialization of CBD and mushrooms-based products. The company's brands include Dr. AnnaRx, Medspresso, and Handcrafted Delight. It is also into research with psilocybin that aims to develop new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. |
URL | https://www.m2bio.co |
Investor Relations URL | N/A |
HQ State/Province | Nevada |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Small Cap/Value |
Next Earnings Release | N/A |
Last Earnings Release | Apr. 01, 2010 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |